Present status and future perspective of peptide‐based vaccine therapy for urological cancer

Use of peptide‐based vaccines as therapeutics aims to elicit immune responses through antigenic epitopes derived from tumor antigens. Peptide‐based vaccines are easily synthesized and lack significant side‐effects when given in vivo. Peptide‐based vaccine therapy against several cancers including ur...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer science 2018-03, Vol.109 (3), p.550-559
Hauptverfasser:	Obara, Wataru, Kanehira, Mitsugu, Katagiri, Toyomasa, Kato, Renpei, Kato, Yoichiro, Takata, Ryo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigen (tumor-associated) Antigens Antigens, Neoplasm - immunology Antitumor activity cancer peptide vaccine therapy Cancer therapies Cancer vaccines Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - immunology Carcinoma, Transitional Cell - drug therapy Carcinoma, Transitional Cell - immunology Cell division Chemotherapy Clinical trials Clinical Trials as Topic Cytokines Epitopes Humans Hypoxia Immune checkpoint inhibitors Immune response Immune system Immunology Immunotherapy Immunotherapy, Active - methods Kidney cancer Kidney Neoplasms - drug therapy Kidney Neoplasms - immunology Kinases Lymphocytes Male Melanoma Metastasis Mutation oncoantigen Peptides Prostate cancer Prostatic Neoplasms - drug therapy Prostatic Neoplasms - immunology renal cell carcinoma Review Survival Analysis Thematic Section: Immunology Treatment Outcome Tumors Urologic Neoplasms - drug therapy Urologic Neoplasms - immunology urothelial cancer Vaccines Vaccines, Subunit - chemical synthesis Vaccines, Subunit - therapeutic use Vascular endothelial growth factor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!